Abstract
Background: Irrigation fluid temperature is a critical but often overlooked factor influencing perioperative hemostasis in transurethral resection of the prostate (TURP). While the clinical consequences of hypothermia are known, its biochemical impact on coagulation and endothelial markers remains incompletely understood.
Methods: Ninety patients with benign prostatic hyperplasia undergoing TURP were randomized into three groups based on irrigation fluid temperature: hypothermia (24–26 °C), mild hypothermia (28–35 °C), and preheating (36–37 °C). Peripheral blood was collected preoperatively and 6 h postoperatively to evaluate coagulation and endothelial indices, including prothrombin time (PT), activated partial thromboplastin time (APTT), platelet count (PLT), platelet aggregation rate (Pagt), and endothelin-1 (ET-1).
Results: Hypothermia significantly prolonged APTT and reduced PLT and Pagt compared with preheating (all P < 0.05), indicating impaired intrinsic pathway activity and platelet dysfunction. PT remained unchanged across groups. ET-1 levels decreased in both hypothermia and preheating groups, with the greatest reduction in preheating, suggesting differential endothelial responses. Patients in the preheating group exhibited preserved coagulation stability and fewer adverse events (6.7%) compared with hypothermia (33.3%) and mild hypothermia (23.3%) groups (P = 0.038).
Conclusion: Hypothermic irrigation during TURP disrupts coagulation and endothelial homeostasis, primarily via intrinsic pathway inhibition and platelet impairment. Laboratory parameters such as APTT, PLT, Pagt, and ET-1 may serve as useful indicators of hypothermia-induced coagulopathy and predictors of perioperative bleeding risk. Integration of these biomarkers into perioperative monitoring could guide thermal management strategies and improve patient outcomes.
Keywords
Array
Array
Array
Array
References
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.